Lynn T. Tanoue, MD, MBA, Chair
Dr. Tanoue is board certified in Internal Medicine, Pulmonary Diseases, and Critical Care Medicine. She is Professor of Medicine in the Section of Pulmonary, Critical Care, and Sleep Medicine, and Vice-Chair for Clinical Affairs in the Department of Internal Medicine at Yale School of Medicine in New Haven, Connecticut. She directs the Yale Screening and Nodule Program at Smilow Cancer Hospital at Yale-New Haven, codirects the Yale Thoracic Oncology Program, and is the principal investigator of the Yale Lung Cancer Biorepository. Her academic focus is in the field of thoracic oncology.
Dr. Tanoue is currently chair of the American Thoracic Society Thoracic Oncology Assembly. She has served in leadership roles in the American College of Chest Physicians and the National Association for the Medical Direction of Respiratory Care. She serves on numerous committees at her home institutions, including as a member of the governing Board of Yale Medicine, and as immediate past-President of the medical staff of Yale New Haven Hospital. Dr. Tanoue is currently President of the Board of Directors of the Yale Medical Symphony Orchestra.
Dr. Tanoue received her bachelor’s degree from Harvard University and medical degree from Yale School of Medicine. She did her internal medicine residency, chief residency and fellowship in pulmonary/critical care medicine at Yale-New Haven Hospital. Dr. Tanoue received her master's in business administration from Yale School of Management.
As of July 2021, Dr. Tanoue reported the following external relationships:
Work as an author or editor for the following companies, with compensation as listed:
- UpToDate®, receiving compensation for authorship.
- Elsevier, receiving compensation as an Editor of Year Book of Pulmonary Disease.
Dr. Tanoue serves in significant roles with the following healthcare-related organization, receiving reimbursement or compensation as listed:
- American Thoracic Society, Chair, Thoracic Oncology Assembly, receiving reimbursement for travel expenses.
- American College of Chest Physicians, faculty, receiving honoraria and reimbursement for travel expenses.
Kathryn Bilello, MD
Dr. Bilello is board certified in Internal Medicine, Pulmonary Diseases, and Critical Care Medicine. She is Clinical Professor of Medicine at University of California, San Francisco (USCF) and is the Program Director for the Pulmonary and Critical Care Medicine fellowship at UCSF-Fresno.
She has served as a member of the In-Service Exam Committee for the Association of Pulmonary and Critical Care Medicine Program Directors. She is currently a member of the Internal Medicine Pulmonary Disease Board. She directs the Lung Cancer Screening Program at Fresno Community Regional Medical Center and has a busy clinical practice which includes all facets of pulmonary and critical care medicine. She delights in sharing her love of medicine with her residents and fellows. When not seeing patients or teaching she enjoys tennis, Crossfit and scuba diving.
Dr. Bilello completed her bachelor's degree in biochemistry with highest honors at University of California, Davis and received her medical degree at New York University. She did her internal medicine residency at University of Maryland, Baltimore and William Beaumont Army Medical Center. She completed her pulmonary and critical care medicine fellowships at Walter Reed Army Medical Center.
As of July 2022, Dr. Bilello reported no external relationships.
Ms. Connor is a patient advocate and volunteer living with pulmonary arterial hypertension, as well as a breast cancer survivor, and a member of the Board of Trustees of the Pulmonary Hypertension Association (PHA). Since her initial diagnosis in 2007, Ms. Connor has dedicated herself to helping and encouraging others with pulmonary hypertension to hope for a cure, and has engaged in numerous advocacy and fundraising activities to advance awareness and research. In 2013, she held the first “Philadelphia’s Hope for a Cure Gala” followed by two additional galas in 2015 and 2017, collectively raising more than $600,000 to benefit PHA. She currently serves as Chair of the PHA Board of Trustees Development Committee and as a member of both the Governance Committee and Strategic Planning Committee. Previously, Ms. Connor served as Vice President of Sales and subsequently Global Sales Operations for SAP America, Inc.
In addition, Ms. Connor volunteers as Co-Leader for the University of Pennsylvania PHA Support Group, and annually in support of the PHA Philadelphia Walk. As an advocate, she has appeared before Congress, participated in PHA’s Advocacy Action Network and presented on pulmonary hypertension to pharmaceutical companies. She has spoken from the patient perspective at PHA international conferences and testified on a PHA panel before the Food and Drug Administration. Ms. Connor was an early advocate of the PHA Registry, an awareness and fundraising initiative, and secured a $25,000 grant from the Robert Wood Johnson Foundation President’s Grant Fund of the Princeton Area Community Foundation to analyze the impact and benefit of pulmonary hypertension patient support groups on patient outcomes. She also served as a patient member for the University of Pennsylvania’s Formal Review and Evaluation as they sought certification to become one of the first PHA Comprehensive Care Centers, and served on the PHA Research Portfolio Working Group. She currently serves on the American Board of Internal Medicine Pulmonary Disease Board.
Following her breast cancer diagnosis in 2018, Ms. Connor has volunteered with Unite for HER, working to establish national partnerships and funding to support underserved patients. Unite for HER recognized Ms. Connor’s service in 2022 with the annual Service Award.
Ms. Connor is a native of Philadelphia, where she completed her undergraduate study at LaSalle University.
As of May 2022, Ms. Connor reported the following external relationships:
- Pulmonary Hypertension Association, Board of Trustees, Development Committee, Governance Committee, and Strategic Planning Committee without compensation
- Department of Defense Congressionally Directed Medical Research Program, Consumer Reviewer, without compensation
Susan Murin, MD
Dr. Murin is currently Vice-Chair of Internal Medicine, Interim Associate Dean for Clinical Affairs and Co-Director of Ambulatory Operations at UC Davis Health System. Former roles at UC Davis include Program Director for the Pulmonary and Critical Care Fellowship, Chief of the Division of Pulmonary, Critical Care and Sleep Medicine, and Chief of the Medical Staff. Her past national service has included membership on the ACGME's Internal Medicine RRC, Chair of the Pulmonary Medicine Test-Writing Committee for the American Board of Internal medicine, and Chair of the Association of Pulmonary and Critical Care Medicine Program Directors. Dr. Murin currently serves as a member of the Internal Medicine Pulmonary Disease Board. She is board certified in Internal Medicine, Pulmonary Medicine, and Critical Care Medicine.
Dr. Murin's research has been focused in two areas: epidemiology of venous thromboembolism and the effects of smoking on the natural history of breast cancer. She remains active in clinical care and teaching at both UC Davis and the Northern California VA. When not working she enjoys spending time with three children, Scuba diving and tennis.
Dr. Murin received her undergraduate degree from Rutgers University and her medical degree at New York University. She completed her residency in Internal Medicine at NYU-Bellevue and fellowship in Pulmonary and Critical Care Medicine at Yale University. She subsequently received an MSc in Clinical Epidemiology from the Harvard School of Public Health and an MBA from the UC Davis Graduate School of Management.
As of June 2022, Dr. Murin reported no external relationships.
Kevin M. O'Neil, MD
Dr. O'Neil is board certified in Internal Medicine, Pulmonary Medicine, Critical Care and Sleep Medicine. He is in private practice and a partner at Wilmington Health, a multispecialty group in Wilmington, North Carolina.
He served in a variety of roles while on active duty including chief medical resident, Chair, Critical Care Medicine, Pulmonary Division Chief, Pulmonary & Critical Care fellowship Program Director, Navy specialty leader for Pulmonary/CCM and GME Director for the National Naval Medical Center.
Dr. O’Neil serves as a member of the American Board of Internal Medicine Pulmonary Disease Board. He is active in clinical practice guideline development with the American College of Chest Physicians and in respiratory care education through the Commission on Accreditation for Respiratory Care (CoARC).
Dr. O’Neil holds an undergraduate degree in chemical engineering from the University of Delaware, a medical degree from Jefferson Medical College in Philadelphia and a master's in healthcare administration from the University of North Carolina at Chapel Hill. He completed his residency and fellowship training at the Naval Hospital in Portsmouth, Virginia.
As of April 2022, Dr. O'Neil reported the following external relationships:
Dr. O’Neil serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American College of Chest Physicians, Past Chair Guidelines Committee, receiving reimbursement for travel expenses.
- Committee on Accreditation for Respiratory Care, Board and Executive Committee Member, serving as President-Elect, receiving reimbursement for travel expenses.
Peter H.S. Sporn, MD
Dr. Sporn is Professor of Medicine and Cell and Molecular Biology at the Feinberg School of Medicine of Northwestern University. He is Program Director of the Northwestern University Pulmonary and Critical Care Fellowship Program, a position he has held since 1996, and since which time he has directed the training of 75 pulmonary and critical fellows. He has been a member of the American Board of Internal Medicine Pulmonary Board Test-writing Committee since 2010.
Dr. Sporn’s clinical interests include asthma, chronic obstructive pulmonary disease, eosinophilic respiratory diseases, interstitial lung diseases and sarcoidosis. His research interests include the role of eicosanoids in lung inflammation, eosinophil biology, mechanosignaling in lung injury and repair, innate immunity and lung host defense. He has been supported by the National Institutes of Health and the Department of Veterans Affairs throughout his research career.
Dr. Sporn received his undergraduate degree from the University of Chicago and his medical degree from Wayne State University School of Medicine. He trained in internal medicine at Bronx Municipal Hospital Center/Albert Einstein College of Medicine and in Pulmonary and Critical Medicine at the University of Michigan.
As of June 2022, Dr. Sporn reported the following external relationships:
Funding for clinical trial expenses and staff, paid to Northwestern University, from the following companies:
- aTyr Pharma
Dr. Sporn serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American Thoracic Society, Scientific Advisory Committee, receiving reimbursement for travel expenses.
- Foundation for Sarcoidosis Research, Grant Reviewer, without compensation.
- National Institutes of Health, Grant Reviewer, receiving reimbursement for travel expenses.
- Respiratory Health Association, Grant Reviewer, without compensation.
- Veterans Affairs, Grant Reviewer, receiving reimbursement for travel expenses.
Grant funding from not-for-profit healthcare-related organizations for project expenses, paid to Northwestern University, from the following organizations:
- American Thoracic Society, receiving funding for project expenses.
- National Institutes of Health, receiving funding for project expenses.
- Foundation for Sarcoidosis Research, receiving funding for project expense and salary support.
- Veterans Affairs, receiving funding for project expenses.
Geneva Tatem, MD
Dr. Tatem is Associate Professor of Medicine at Wayne State University School of Medicine and the Program Director for the Pulmonary and Critical Care Medicine and multispecialty Critical Care Medicine fellowship programs at Henry Ford Hospital. She also serves as the Associate Division Head of Pulmonary and Critical Care Medicine.
Dr. Tatem served as chair of the graduate medical education committee, of which she remains an active member. She also chaired the medical education advocacy team focused on raising awareness of medical education funding needs in the Michigan State Legislature. Her academic interest is on process improvement as applied to medical education. She has guided each of her fellowship programs through curriculum innovations, most recently behavioral based interviews for fellowship recruitment. She was a physician lead for the education and training team in the Sepsis Project, a transformational system redesign process to improve the effectiveness of sepsis care throughout the 5 hospitals within Henry Ford Health System (HFHS) and earned a Focus on People award from the HFHS Board of Governors in recognition for her commitment to process improvement and patient safety throughout the health system.
Dr. Tatem is a Fellow of the American College of Chest Physicians and is actively involved in the Association of Pulmonary and Critical Care Medicine Program Directors, the Section of Medical Education of the American Thoracic Society, the Society of Critical Care Medicine, and the National Medical Association.
Dr. Tatem received a bachelor of science degree in chemical engineering at Cornell University and earned her medical degree from the University of Michigan School of Medicine. She completed her internship in Emergency Medicine at the University of Chicago and completed residency in internal medicine and fellowship in pulmonary and critical care Medicine at Henry Ford Hospital. She joined the faculty at Henry Ford Hospital in 2007.
As of September 2021, Dr. Tatem reported no external relationships.
Corinne R. Young, NP, FCCP
Ms. Young is a Nurse Practitioner (NP) who began working in pulmonary disease in California in 2005, and since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Ms. Young is currently one of the first 10 Advanced Practice Providers nationwide to become a Fellow of the American College of Chest Physicians.
Involvement and the representation of advanced practice providers in the pulmonary world has been one of her priorities, Ms. Young founded and is the President of the Association of Pulmonary Advanced Practice Providers (APAPP), a community for nurse practitioners and physician assistants working in pulmonary medicine. She also works closely with the American College of Chest Physicians’ CHEST programs and serves on the Interprofessional Team Network, Clinical Research Network. Additionally, Ms. Young is a member of the American Board of Internal Medicine Pulmonary Disease Board.
Ms. Young's education started as a bachelor's-prepared registered nurse working in critical care in medical, surgical, cardiac and trauma ICUs. She then pursued her master's degree in nursing at California State University, Bakersfield Family Practice Nurse Practitioner program and became board certified in Family Practice through the American Association of Nurse Practitioners.
As of April 2022, Ms. Young reported the following external relationships:
Funding for clinical trial expenses, paid to Colorado Springs Pulmonary Consultants, from the following companies:
- Janssen, for a trial for treatment of chronic thromboembolic pulmonary hypertension.
- GlaxoSmithKline, for a trial for treatment of chronic obstructive pulmonary disease exacerbations.
Service on a research-related expert panel or advisory board for the following company, without compensation:
- Takeda, serving on an Alpha-1 Antitrypsin Deficiency advisory board.
Ms. Young serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- Association of Pulmonary Advanced Practice Providers, President and Founder, receiving reimbursement for travel expenses.